Mutually exclusive teams-like patterns of gene regulation characterize phenotypic heterogeneity along the noradrenergic-mesenchymal axis in neuroblastoma

Neuroblastoma is the most frequent extracranial pediatric tumor and leads to 15% of all cancer-related deaths in children. Tumor relapse and therapy resistance in neuroblastoma are driven by phenotypic plasticity and heterogeneity between noradrenergic (NOR) and mesenchymal (MES) cell states. Despite the importance of this phenotypic plasticity, the dynamics and molecular patterns associated with these bidirectional cell-state transitions remain relatively poorly understood. Here, we analyze multiple RNA-seq datasets at both bulk and single-cell resolution, to understand the association between NOR- and MES-specific factors. We observed that NOR-specific and MES-specific expression patterns are largely mutually exclusive, exhibiting a "teams-like" behavior among the genes involved, reminiscent of our earlier observations in lung cancer and melanoma. This antagonism between NOR and MES phenotypes was also associated with metabolic reprogramming and with immunotherapy targets PD-L1 and GD2 as well as with experimental perturbations driving the NOR-MES and/or MES-NOR transition. Further, these "teams-like" patterns were seen only among the NOR- and MES-specific genes, but not in housekeeping genes, possibly highlighting a hallmark of network topology enabling cancer cell plasticity.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:25

Enthalten in:

Cancer biology & therapy - 25(2024), 1 vom: 31. März, Seite 2301802

Sprache:

Englisch

Beteiligte Personen:

Sehgal, Manas [VerfasserIn]
Nayak, Sonali Priyadarshini [VerfasserIn]
Sahoo, Sarthak [VerfasserIn]
Somarelli, Jason A [VerfasserIn]
Jolly, Mohit Kumar [VerfasserIn]

Links:

Volltext

Themen:

GD2
Journal Article
Mesenchymal-noradrenergic transition
Neuroblastoma
Noradrenergic-mesenchymal transition
Phenotypic heterogeneity
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 18.01.2024

Date Revised 11.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/15384047.2024.2301802

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM367211254